Predicting the cumulative risk of false-positive mammograms.

BACKGROUND The cumulative risk of a false-positive mammogram can be substantial. We studied which variables affect the chance of a false-positive mammogram and estimated cumulative risks over nine sequential mammograms. METHODS We used medical records of 2227 randomly selected women who were 40-69 years of age on July 1, 1983, and had at least one screening mammogram. We used a Bayesian discrete hazard regression model developed for this study to test the effect of patient and radiologic variables on a first false-positive screening and to calculate cumulative risks of a false-positive mammogram. RESULTS Of 9747 screening mammograms, 6. 5% were false-positive; 23.8% of women experienced at least one false-positive result. After nine mammograms, the risk of a false-positive mammogram was 43.1% (95% confidence interval [CI] = 36.6%-53.6%). Risk ratios decreased with increasing age and increased with number of breast biopsies, family history of breast cancer, estrogen use, time between screenings, no comparison with previous mammograms, and the radiologist's tendency to call mammograms abnormal. For a woman with highest-risk variables, the estimated risk for a false-positive mammogram at the first and by the ninth mammogram was 98.1% (95% CI = 69.3%-100%) and 100% (95% CI = 99.9%-100%), respectively. A woman with lowest-risk variables had estimated risks of 0.7% (95% CI = 0.2%-1.9%) and 4.6% (95% CI = 1. 1%-12.5%), respectively. CONCLUSIONS The cumulative risk of a false-positive mammogram over time varies substantially, depending on a woman's own risk profile and on several factors related to radiologic screening. By the ninth mammogram, the risk can be as low as 5% for women with low-risk variables and as high as 100% for women with multiple high-risk factors.

[1]  A. Gelfand,et al.  Modelling the cumulative risk for a false-positive under repeated screening events. , 2000, Statistics in medicine.

[2]  B. Kuska Mass breast cancer screening in The Netherlands: 10 years and counting. , 1998, Journal of the National Cancer Institute.

[3]  E White,et al.  Variation in mammographic breast density by time in menstrual cycle among women aged 40-49 years. , 1998, Journal of the National Cancer Institute.

[4]  C J Baines,et al.  Menstrual cycle variation in mammographic breast density: so who cares? , 1998, Journal of the National Cancer Institute.

[5]  E. Halpern,et al.  Previous breast biopsy for benign disease rarely complicates or alters interpretation on screening mammography. , 1998, AJR. American journal of roentgenology.

[6]  J. Elmore,et al.  Ten-year risk of false positive screening mammograms and clinical breast examinations. , 1998, The New England journal of medicine.

[7]  R Tibshirani,et al.  Impact of menstrual phase on false‐negative mammograms in the canadian national breast screening study , 1997, Cancer.

[8]  A R Feinstein,et al.  The impact of clinical history on mammographic interpretations. , 1997, JAMA.

[9]  R. J. Brenner,et al.  Mammographic changes after excisional breast biopsy for benign disease. , 1996, AJR. American journal of roentgenology.

[10]  G J Whitman,et al.  Positive predictive value of breast biopsy performed as a result of mammography: there is no abrupt change at age 50 years. , 1996, Radiology.

[11]  S. Taplin,et al.  Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. , 1996, Journal of the National Cancer Institute.

[12]  E. Jonsson,et al.  Neglected aspects of false positive findings of mammography in breast cancer screening: analysis of false positive cases from the Stockholm trial , 1996, BMJ.

[13]  E A Sickles,et al.  Screening mammography in community practice: positive predictive value of abnormal findings and yield of follow-up diagnostic procedures. , 1995, AJR. American journal of roentgenology.

[14]  Jo M. Kendrick,et al.  Quality Determinants of Mammography, Clinical Practice Guideline , 1995 .

[15]  G A Colditz,et al.  The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. , 1995, The New England journal of medicine.

[16]  E A Sickles,et al.  Initial versus subsequent screening mammography: comparison of findings and their prognostic significance. , 1995, AJR. American journal of roentgenology.

[17]  B. Rimer,et al.  Psychosocial effects of abnormal Pap tests and mammograms: A review , 1995 .

[18]  K. Kerlikowske,et al.  Positive predictive value of screening mammography by age and family history of breast cancer. , 1993, JAMA.

[19]  S Shapiro,et al.  Report of the International Workshop on Screening for Breast Cancer. , 1993, Journal of the National Cancer Institute.

[20]  J. Manson,et al.  Family history, age, and risk of breast cancer. Prospective data from the Nurses' Health Study. , 1993, JAMA.

[21]  Marydale Debor,et al.  Quality determinants of mammography , 1993 .

[22]  G. Colditz,et al.  Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies. , 1993, American journal of obstetrics and gynecology.

[23]  R. Houlston,et al.  Family history and risk of breast cancer. , 1992, Journal of medical genetics.

[24]  S. Thacker,et al.  A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. , 1991, JAMA.

[25]  A. Bull,et al.  Assessment of the psychological impact of a breast screening programme. , 1991, The British journal of radiology.

[26]  B. Trock,et al.  Psychological and behavioral implications of abnormal mammograms. , 1991, Annals of internal medicine.

[27]  I. Gram,et al.  Quality of life following a false positive mammogram. , 1990, British Journal of Cancer.

[28]  Adrian F. M. Smith,et al.  Sampling-Based Approaches to Calculating Marginal Densities , 1990 .

[29]  E A Sickles,et al.  Medical audit of a rapid-throughput mammography screening practice: methodology and results of 27,114 examinations. , 1990, Radiology.

[30]  M. Gail,et al.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.

[31]  S. Moss,et al.  Psychiatric morbidity associated with screening for breast cancer. , 1989, British Journal of Cancer.

[32]  L. Fajardo,et al.  Correlation between breast parenchymal patterns and mammographers' certainty of diagnosis. , 1988, Investigative radiology.

[33]  L. Tabár,et al.  Significant reduction in advanced breast cancer. Results of the first seven years of mammography screening in Kopparberg, Sweden. , 1985, Diagnostic imaging in clinical medicine.

[34]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[35]  D.,et al.  Regression Models and Life-Tables , 2022 .